Kalaris Therapeutics names Liisa Bayko as CFO
Go back to Kalaris Therapeutics names Liisa Bayko as CFO| (NASDAQ: KLRS) | Delayed: 1.86 +0.06 (3.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.80 | 52 Week High | $ | |||
| Open | $1.78 | 52 Week Low | $ | |||
| Day High | $1.88 | P/E | N/A | |||
| Day Low | $1.78 | EPS | $ | |||
| Volume | 50,127 | |||||



